-
Prospective Bladder Cancer Infrastructure (ProBCI) - European expansion?
The Prospective Bladder Cancer Infrastructure (ProBCI) was launched in the Netherlands in 2020, and has since accrued almost 1000 patients from 22 centres. Its flexible design and use of trials within-cohorts studies has clear advantages for researchers. The model could potentially be applied to other countries in Europe with a certain amount of financial support.03-20
2024
> -
Double JJ Ureteral Stenting: Encrustation and Tolerabilit
The European Association of Urology (EAU) guidelines support ureteric stenting after ureteroscopy in cases with a higher risk of complications.04-26
2021
> -
Radical Cystectomy versus Trimodality
The EAU and AUA guidelines recommend that patients who are fit should be offered radical cystectomy, reserving TMT for those who are less fit.03-24
2021
> -
Evaluation of gene therapy for Nadofaragene firadenovec by researchers at the University of Toronto
High-risk non-muscle-invasive bladder cancer unresponsive to BCG therapy is notoriously difficult to treat, recurs at an extremely high rate, and can progress to muscle invasion and metastases.01-19
2021
> -
Diagnosis and evaluation of urolithiasis
The most appropriate imaging modality will be determined by the clinical situation, which will differ depending on if a ureteral or a renal stone is suspected.01-18
2021
>